China NMPA Product Recall - SERFAS ENERGY SUPER 90-S Ablation Electrode

The National Medical Products Administration (NMPA) issued a notice on November 23, 2011, detailing a voluntary recall by Stryker Endoscopy. The recall concerned specific lots of its SERFAS ENERGY SUPER 90-S Ablation Electrode (Model 279-351-300, Lot Numbers 11161AE2~11241AE2) due to a high risk of tip breakage, which could compromise patient safety during arthroscopic surgeries. Stryker (Beijing) Medical Devices Co., Ltd., the local responsible entity, clarified that the affected models are not registered, nor have they been sold or imported into the Chinese market. Therefore, this particular recall has no direct impact on China, and no products require recall actions within the country. However, operating under the NMPA's regulatory framework, the food and drug administrations across Chinese provinces, autonomous regions, and municipalities were instructed to enhance their supervision of similar medical devices. The primary regions affected by this recall include Australia, Canada, India, Japan, Puerto Rico, South Africa, Hong Kong, and several European nations.